What conditions does Vanda Pharmaceuticals run trials for?

In our tracked recruiting trials, Vanda Pharmaceuticals sponsors trials for Schizophrenia, Bipolar I Disorder, Bipolar disorder.

Clinical trials sponsored by Vanda Pharmaceuticals

Recruiting trials

Conditions studied

Phase 3 5Phase 4 1

Condition	Trials
Schizophrenia	2
Bipolar I Disorder	1
Bipolar disorder	1
Depression	1
Major Depressive Disorder (MDD)	1
Moderate-to-severe Chronic Plaque Psoriasis	1
Nausea and Vomiting	1
Obesity	1
Psoriasis	1
Ulcerative Colitis (UC)	1
Ulcerative colitis	1

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
NCT07446439 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 10 locations
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
NCT06830044 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 38 locations
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
NCT07362017 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 4 locations
Randomized Withdrawal Study in Patients With Schizophrenia
NCT06961968 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 22 locations
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
NCT05648591 · Phase: Phase 4 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 9 locations
Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
NCT07686081 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations